IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 36 filers reported holding IRADIMED CORP in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $879,000 | -34.6% | 23,648 | -63.5% | 0.31% | -1.9% |
| Q2 2018 | $1,345,000 | +40.5% | 64,796 | -2.5% | 0.31% | +54.2% |
| Q1 2018 | $957,000 | -5.7% | 66,476 | -0.7% | 0.20% | +3.0% |
| Q4 2017 | $1,015,000 | +50.4% | 66,976 | -4.7% | 0.20% | +99.0% |
| Q3 2017 | $675,000 | +11.4% | 70,276 | -0.3% | 0.10% | +37.5% |
| Q2 2017 | $606,000 | +2.2% | 70,476 | +5.7% | 0.07% | +24.1% |
| Q1 2017 | $593,000 | +0.2% | 66,653 | +25.0% | 0.06% | +18.4% |
| Q4 2016 | $592,000 | -32.1% | 53,314 | +3.9% | 0.05% | -41.0% |
| Q3 2016 | $872,000 | -4.4% | 51,314 | +22.4% | 0.08% | -33.6% |
| Q2 2016 | $912,000 | +40.7% | 41,919 | +23.9% | 0.12% | +40.4% |
| Q1 2016 | $648,000 | -19.2% | 33,833 | +18.3% | 0.09% | -12.7% |
| Q4 2015 | $802,000 | +219.5% | 28,603 | +177.8% | 0.10% | +155.0% |
| Q3 2015 | $251,000 | – | 10,297 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nine Ten Capital Management LLC | 715,877 | $32,100,000 | 4.18% |
| Soleus Capital Management, L.P. | 430,051 | $19,283,000 | 2.49% |
| RESOURCE CONSULTING GROUP INC | 128,000 | $5,740,000 | 1.99% |
| RK Capital | 213,200 | $9,560,000 | 1.88% |
| Capital Impact Advisors, LLC | 22,797 | $1,022,000 | 0.74% |
| G2 Investment Partners Management LLC | 61,326 | $2,750,000 | 0.65% |
| EAM Investors, LLC | 76,179 | $3,416,000 | 0.64% |
| Ranger Investment Management | 193,306 | $8,668,000 | 0.55% |
| EAM Global Investors LLC | 42,885 | $1,923,000 | 0.36% |
| Hillsdale Investment Management Inc. | 121,500 | $5,448,000 | 0.35% |